Clinical application of proteomics approaches in vascular diseases

Proteomics - Clinical Applications

Volumn 2, Issue 2, 2008, Pages 238-250

  Wang, Xiao Li ^a   Fu, Alex ^a   Spiro, Craig ^a   Lee, Hon Chi ^a  

^a MAYO CLINIC   (United States)

Author keywords

Biomarker; Mass spectrometry; Protein expression; Vascular disease

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; BIOLOGICAL MARKER; BRADYKININ ANTAGONIST; BRADYKININ B2 RECEPTOR; CARBONATE DEHYDRATASE I; CELL MEMBRANE PROTEIN; COMPLEMENT COMPONENT C1S INHIBITOR; CYTOKINE; GROWTH FACTOR; HEAT SHOCK PROTEIN; HORMONE; KALLISTATIN; MATRIX METALLOPROTEINASE; OXIDIZED LOW DENSITY LIPOPROTEIN; PLASMA PROTEIN; PREKALLIKREIN; PROTEINASE INHIBITOR; PROTEOME; UNCLASSIFIED DRUG;

ADVENTITIA; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL MIGRATION; CELL PROLIFERATION; COMPLEX FORMATION; DEATH; DEVELOPING COUNTRY; DIABETES MELLITUS; HUMAN; HYPERTENSION; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; MONOCYTE; MORBIDITY; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROCESSING; PROTEIN SYNTHESIS INHIBITION; PROTEOMICS; REGULATORY MECHANISM; REVIEW; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

EID: 39649123510     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200780005     Document Type: Review

References (104)

1. Granger, C. B., Van Eyk, J. E., Mockrin, S. C., Anderson, N. L. et al., National Heart, Lung, And Blood Institute Clinical Proteomics Working Group report. Circulation 2004, 109, 1697-1703.
2. Mayr, M., Zhang, J., Greene, A. S., Gutterman, D. et al., Proteomics-based development of biomarkers in cardiovascular disease: Mechanistic, clinical, and therapeutic insights. Mol. Cell. Proteomics 2006, 5, 1853-1864.
3. Lovestone, S., Guntert, A., Hye, A., Lynham, S. et al., Proteomics of Alzheimer's disease: Understanding mechanisms and seeking biomarkers. Expert Rev. Proteomics 2007, 4, 227-238.
4. Jung, E. J., Moon, H. G., Cho, B. I., Jeong, C. Y. et al., Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer. Int. J. Cancer 2007, 120, 2331-2338.
5. Zhu, Y., Wu, R., Sangha, N., Yoo, C. et al., Classifications of ovarian cancer tissues by proteomic patterns. Proteomics 2006, 6, 5846-5856.
6. Theodorescu, D., Wittke, S., Ross, M. M., Walden, M. et al., Discovery and validation of new protein biomarkers for urothelial cancer: A prospective analysis. Lancet Oncol. 2006, 7, 230-240.
7. Morita, A., Miyagi, E., Yasumitsu, H., Kawasaki, H. et al., Proteomic search for potential diagnostic markers and therapeutic targets for ovarian clear cell adenocarcinoma. Proteomics 2006, 6, 5880-5890.
8. Chambers, G., Lawrie, L., Cash, P., Murray, G. I., Proteomics: A new approach to the study of disease. J. Pathol. 2000, 192, 280-288.
9. Berhane, B. T., Zong, C., Liem, D. A., Huang, A. et al., Cardiovascular-related proteins identified in human plasma by the HUPO Plasma Proteome Project pilot phase. Proteomics 2005, 5, 3520-3530.
10. Blanco-Colio, L. M., Martin-Ventura, J. L., Vivanco, F., Michel, J.-B. et al., Biology of atherosclerotic plaques: What we are learning from proteomic analysis. Cardiovasc. Res. 2006, 72, 18-29.
11. Donahue, M. P., Rose, K., Hochstrasser, D., Vonderscher, J. et al., Discovery of proteins related to coronary artery disease using industrial-scale proteomics analysis of pooled plasma. Am. Heart J. 2006, 152, 478-485.
12. Donners, M. M., Verluyten, M. J., Bouwman, F. G., Mariman, E. C. et al., Proteomic analysis of differential protein expression in human atherosclerotic plaque progression. J. Pathol. 2005, 206, 39-45.
13. Drake, T. A., Ping, P., Thematic review series: Systems biology approaches to metabolic and cardiovascular disorders. Proteomics approaches to the systems biology of cardiovascular diseases. J. Lipid Res. 2007, 48, 1-8.
14. Schiffer, E., Mischak, H., Novak, J., High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS. Proteomics 2006, 6, 5615-6627.
15. Arrell, D. K., Neverova, I., Van Eyk, J. E., Cardiovascular proteomics: Evolution anal potential. Circ. Res. 2001, 88, 763-773.
16. McGregor, E., Dunn, M. J., Proteomics of the heart: Unraveling disease. Circ. Res. 2006, 98, 309-321.
17. McGregor, E., Dunn, M. J., Proteomics of heart disease. Hum. Mol. Genet. 2003, 12, R135-R144.
18. Anderson, N. L., Polanski, M., Pieper, R., Gatlin, T. et al., The human plasma proteome: A nonredundant list developed by combination of four separate sources. Mol. Cell. Proteomics 2004, 3, 311-326.
19. Anderson, N. L., Anderson, N. G., The human plasma proteome: History, character, and diagnostic prospects. [Erratum appears in Mol. Cell. Proteomics 2003, 2(1), 50]. Mol. Cell. Proteomics 2002, 1, 845-867.
20. Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F. et al., Quantitative analysis of complex protein mixtures using isotopecoded affinity tags. Nat. Biotechnol. 1999, 17, 994-999.
21. Yao, X., Freas, A., Ramirez, J., Demirev, P. A. et al., Proteolytic 180 labeling for comparative proteomics: Model studies with two serotypes of adenovirus. Anal Chem. 2001, 73, 2836-2842.
22. Ross, P. L., Huang, Y. N., Marchese, J. N., Williamson, B. et al., Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 2004, 3, 1154-1169.
23. Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B. et al., Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 2002, 1, 376-386.
24. Lu, P., Vogel, C., Wang, R., Yao, X. et al., Absolute protein expression profiling estimates the relative contributions of transcriptional and translational regulation. Nat. Biotechnol. 2007, 25, 117-124.
25. Mallick, P., Schirle, M., Chen, S. S., Flory, M. R. et al., Computational prediction of proteotypic peptides for quantitative proteomics. Nat. Biotechnol. 2007, 25, 125-131.
26. Bergeron, J. J., Hallett, M., Peptides you can count on. Nat. Biotechnol. 2007, 25, 61-62.
27. Kuhner, S., Gavin, A. C., Towards quantitative analysis of proteome dynamics. Nat. Biotechnol. 2007, 25, 298-300.
28. Gao, B. B., Clermont, A., Rook, S., Fonda, S. J. et al., Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. [See comment]. Nat. Med. 2007, 13, 181-188.
29. Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., III et al., ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007, 316, 1160-1166.
30. Pohl, U., Holtz, J., Busse, R., Bassenge, E., Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension 1986, 8, 37-44.
31. Langille, B. L., O'Donnell, F., Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science 1986, 231, 405-407.
32. Dull, R. O., Jaffe, H. A., Ge, M., Ryan, T. L., Malik, A. B., in: Crystal, R. G., West, J. B., Weibel, E. R., Barnes, P. J. (Eds.), The Lung, Lippincott-Raven, Philadelphia 1997, pp. 653-662.
33. Quyyumi, A. A., Endothelial function in health and disease: New insights into the genesis of cardiovascular disease. Am. J. Med. 1998, 105, 32S-39S.
34. Bruneel, A., Labas, V., Mailloux, A., Sharma, S. et al., Proteomic study of human umbilical vein endothelial cells in culture. Proteomics 2003, 3, 714-723.
35. Bianchi, L., Lorenzoni, P., Bini, L., Weber, E. et al., Protein expression profiles of Bos taurus blood and lymphatic vessel endothelial cells. Proteomics 2007, 7, 1600-1614.
36. Lu, L., Yang, P. Y., Rui, Y., Kang, H. et al., Comparative proteome analysis of rat brain and coronary microvascular endothelial cells. Physiol. Res. 2007, 56, 159-168.
37. Kinumi, T., Ogawa, Y., Kimata, J., Saito, Y. et al., Proteomic characterization of oxidative dysfunction in human umbilical vein endothelial cells (HUVEC) induced by exposure to oxidized LDL. Free Radic. Res. 2005, 39, 1335-1344.
38. Fuchs, D., Erhard, P., Turner, R., Rimbach, G. et al., Genistein reverses changes of the proteome induced by oxidized-LDL in EA.hy 926 human endothelial cells. J. Proteome Res. 2005, 4, 369-376.
39. Predescu, D., Palade, G. E., Plasmalemmal vesicles represent the large pore system of continuous microvascular endothelium. Am. J. Physiol. 1993, 265, H725-H733.
40. Minshall, R. D., Sessa, W. C., Stan, R. V., Anderson, R. G. et al., Caveolin regulation of endothelial function. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 285, L1179-L1183.
41. Sprenger, R. R., Speijer, D., Back, J. W., De Koster, C. G. et al., Comparative proteomics of human endothelial cell caveolae and rafts using two-dimensional gel electrophoresis and mass spectrometry. Electrophoresis 2004, 25, 156-172.
42. Guo, Y., Singleton, P. A., Rowshan, A., Gucek, M. et al., Quantitative proteomics analysis of human endothelial cell membrane rafts: Evidence of MARCKS and MRP regulation in the sphingosine 1-phosphate-induced barrier enhancement. Mol. Cell. Proteomics 2007, 6, 689-696.
43. Garcia, J. G., Liu, F., Verin, A. D., Birukova, A. et al., Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J. Clin. Invest. 2001, 108, 689-701.
44. McVerry, B. J., Garcia, J. G., In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: Mechanistic insights. Cell. Signal. 2005, 17, 131-139.
45. Wang, X. L., Fu, A., Raghavakaimal, S., Lee, H. C., Proteomic analysis of vascular endothelial cells in response to laminar shear stress. Proteomics 2007, 7, 588-596.
46. Owens, G. K., Kumar, M. S., Wamhoff, B. R., Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 2004, 84, 767-801.
47. Pshezhetsky, A. V., Proteomic analysis of vascular smooth muscle cells treated with ouabain. Methods Mol. Biol. 2007, 357, 253-269.
48. Boccardi, C., Cecchettini, A., Caselli, A., Camici, G. et al., A proteomic approach to the investigation of early events involved in the activation of vascular smooth muscle cells. Cell Tissue Res. 2007, 329, 119-128.
49. Lee, C. K., Park, H. J., So, H. H., Kim, H. J. et al., Proteomic profiling and identification of cofilin responding to oxidative stress in vascular smooth muscle. Proteomics 2006, 6, 6455-6475.
50. Molero, L., Garcia-Mendez, A., Alonso-Orgaz, S., Carrasco, C. et al., Proteomic approach to identify changes in protein expression modified by 17beta-oestradiol in bovine vascular smooth muscle cells. Clin. Sci. (Lond.) 2005, 109, 457-463.
51. Wassmann, S., Wassmann, K., Nickenig, G., Regulation of antioxidant and oxidant enzymes in vascular cells and implications for vascular disease. Curr. Hypertens. Rep. 2006, 8, 69-78.
52. de Champlain, J., Wu, R., Girouard, H., Karas, M. et al., Oxidative stress in hypertension. Clin. Exp. Hypertens. 2004, 26, 593-601.
53. Mayr, M., Siow, R., Chung, Y. L., Mayr, U. et al., Proteomic and metabolomic analysis of vascular smooth muscle cells: Role of PKCdelta. Circ. Res. 2004, 94, e87-e96.
54. Stenmark, K. R., Davie, N., Frid, M., Gerasimovskaya, E. et al., Role of the adventitia in pulmonary vascular remodeling. Physiology (Bethesda) 2006, 21, 134-145.
55. Shi, Y., Niculescu, R., Wang, D., Patel, S. et al., Increased NAD(P)H oxidase and reactive oxygen species in coronary arteries after balloon injury. Arterioscler. Thromb. Vasc. Biol. 2001, 21, 739-745.
56. Tamura, K., Kanzaki, T., Tashiro, J., Yokote, K. et al., Increased atherogenesis in Otsuka Long-Evans Tokushima fatty rats before the onset of diabetes mellitus: Association with overexpression of PDGF beta-receptors in aortic smooth muscle cells. Atherosclerosis 2000, 149, 351-358.
57. Capers, Q. t., Alexander, R. W., Lou, P., De Leon, H. et al., Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats. Hypertension 1997, 30, 1397-1402.
58. Antohe, F., Endothelial cells and macrophages, partners in atherosclerotic plaque progression. Arch. Physiol. Biochem. 2006, 112, 245-253.
59. Llodra, J., Angeli, V., Liu, J., Trogan, E. et al., Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc. Natl. Acad. Sci. USA 2004, 101, 11779-11784.
60. Barderas, M. G., Tunon, J., Darde, V. M., De la Cuesta, F. et al., Circulating human monocytes in the acute coronary syndrome express a characteristic proteomic profile. J. Proteome Res. 2007, 6, 876-886.
61. Gonzalez-Barderas, M., Gallego-Delgado, J., Mas, S., Duran, M. C. et al., Isolation of circulating human monocytes with high purity for proteomic analysis. Proteomics 2004, 4, 432-437.
62. Yu, Y. L., Huang, Z. Y., Yang, P. Y., Rui, Y. C., Proteomic studies of macrophage-derived foam cell from human U937 cell line using two-dimensional gel electrophoresis and tandem mass spectrometry. J. Cardiovasc. Pharmacol. 2003, 42, 782-789.
63. Yang, P. Y., Rui, Y. C., Yu, Y. L., Proteomic analysis of foam cells. Methods Mol. Biol. 2007, 357, 297-305.
64. Kang, J. H., Kim, H. T., Choi, M. S., Lee, W. H. et al., Proteome analysis of human monocytic THP-1 cells primed with oxidized low-density lipoproteins. Proteomics 2006, 6, 1261-1273.
65. Vivanco, F., Martin-Ventura, J. L., Duran, M. C., Barderas, M. G. et al., Quest for novel cardiovascular biomarkers by proteomic analysis. J. Proteome Res. 2005, 4, 1181-1191.
66. Conway, J. P., Kinter, M., Proteomic and transcriptomic analyses of macrophages with an increased resistance to oxidized low density lipoprotein (oxLDL)-induced cytotoxicity generated by chronic exposure to oxLDL. Mol. Cell. Proteomics 2005, 4, 1522-1540.
67. Fuchs, D., de Pascual-Teresa, S., Rimbach, G., Virgili, F. et al., Proteome analysis for identification of target proteins of genistein in primary human endothelial cells stressed with oxidized LDL or homocysteine. Eur. J. Nutr. 2005, 44, 95-104.
68. Brownlee, M., Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414, 813-820.
69. Libby, P., Inflammation in atherosclerosis. Nature 2002, 420, 868-874.
70. Madamanchi, N. R., Vendrov, A., Runge, M. S., Oxidative stress and vascular disease. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 29-38.
71. Paravicini, T. M., Touyz, R. M., Redox signaling in hypertension. Cardiovasc. Res. 2006, 71, 247-258.
72. Hajjar, I., Kotchen, T. A., Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. [See comment]. JAMA 2003, 290, 199-206.
73. Thongboonkerd, V., Gozal, E., Sachleben, L. R., Jr., Arthur, J. M. et al., Proteomic analysis reveals alterations in the renal kallikrein pathway during hypoxia-induced hypertension. J. Biol. Chem. 2002, 277, 34708-34716.
74. Sironi, L., Tremoli, E., Miller, I., Guerrini, U. et al., Acutephase proteins before cerebral ischemia in stroke-prone rats: Identification by proteomics. Stroke 2001, 32, 753-760.
75. Jin, X., Xia, L., Wang, L. S., Shi, J. Z. et al., Differential protein expression in hypertrophic heart with and without hypertension in spontaneously hypertensive rats. [Erratum appears in Proteomics 2006, 6(7), 2326. Proteomics 2006, 6, 1948-1966.
76. Gallego-Delgado, J., Lazaro, A., Osende, J. I., Barderas, M. G. et al., Comparison of the protein profile of established and regressed hypertension-induced left ventricular hypertrophy. J. Proteome Res. 2006, 5, 404-413.
77. Beckman, J. A., Creager, M. A., Libby, P., Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management. JAMA 2002, 287, 2570-2581.
78. Zimmet, P., Alberti, K. G., Shaw, J., Global and societal implications of the diabetes epidemic. Nature 2001, 414, 782-787.
79. Roglic, G., Unwin, N., Bennett, P. H., Mathers, C. et al., The burden of mortality attributable to diabetes: Realistic estimates for the year 2000. [See comment]. Diabetes Care 2005, 28, 2130-2135.
80. Otu, H. H., Can, H., Spentzos, D., Nelson, R. G. et al., Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy. Diabetes Care 2007, 30, 638-643.
81. Kim, H. J., Cho, E. H., Yoo, J. H., Kim, P. K. et al., Proteome analysis of serum from type 2 diabetics with nephropathy. J. Proteome Res. 2007, 6, 735-743.
82. Shen, X., Zheng, S., Thongboonkerd, V., Xu, M. et al., Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes. Am. J. Physiol. Endocrinol. Metab. 2004, 287, E896-E905.
83. Kempen, J. H., O'Colmain, B. J., Leske, M. C., Haffner, S. M. et al., The prevalence of diabetic retinopathy among adults in the United States. Arch. Ophthal. 2004, 122, 552-563.
84. Sparre, T., Larsen, M. R., Heding, P. E., Karlsen, A. E. et al., Unraveling the pathogenesis of type 1 diabetes with proteomics: Present and future directions. Mol. Cell. Proteomics 2005, 4, 441-457.
85. Sparre, T., Christensen, U. B., Gotfredsen, C. F., Larsen, P. M. et al., Changes in expression of IL-1 beta influenced proteins in transplanted islets during development of diabetes in diabetes-prone BB rats. Diabetologia 2004, 47, 892-908.
86. Sparre, T., Christensen, U. B., Mose Larsen, P., Fey, S. J. et al., IL-1beta induced protein changes in diabetes prone BB rat islets of Langerhans identified by proteome analysis. Diabetologia 2002, 45, 1550-1561.
87. Winer, S., Tsui, H., Lau, A., Song, A. et al., Autoimmune islet destruction in spontaneous type 1 diabetes is not beta-cell exclusive. [See comment]. Nat. Med. 2003, 9, 198-205.
88. You, S. A., Archacki, S. R., Angheloiu, G., Moravec, C. S. et al., Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: Evidence consistent with iron hypothesis in atherosclerosis. Physiol. Genomics 2003, 13, 25-30.
89. Martinet, W., Schrijvers, D. M., De Meyer, G. R., Herman, A. G. et al., Western array analysis of human atherosclerotic plaques: Downregulation of apoptosis-linked gene 2. [See comment]. Cardiovas. Res. 2003, 60, 259-267.
90. Duran, M. C., Mas, S., Martin-Ventura, J. L., Meilhac, O. et al., Proteomic analysis of human vessels: Application to atherosclerotic plaques. Proteomics 2003, 3, 973-978.
91. Almofti, M. R., Huang, Z., Yang, P., Rui, Y., Proteomic analysis of rat aorta during atherosclerosis induced by high cholesterol diet and injection of vitamin D3. Clin. Exp. Pharmacol. Physiol. 2006, 33, 305-309.
92. Zhang, S. H., Reddick, R. L., Piedrahita, J. A., Maeda, N., Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992, 258, 468-471.
93. Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setala, K. et al., Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992, 71, 343-353.
94. Mayr, M., Chung, Y. L., Mayr, U., Yin, X. et al., Proteomic and metabolomic analyses of atherosclerotic vessels from apolipoprotein E-deficient mice reveal alterations in inflammation, oxidative stress, and energy metabolism. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 2135-2142.
95. t Hoen, P. A., Van der Lans, C. A., Van Eck, M., Bijsterbosch, M. K. et al., Aorta of ApoE-deficient mice responds to atherogenic stimuli by a prelesional increase and subsequent decrease in the expression of antioxidant enzymes. [See comment]. Circ. Res. 2003, 93, 262-269.
96. Martin-Ventura, J. L., Duran, M. C., Blanco-Colio, L. M., Meilhac, O. et al., Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis. Circulation 2004, 110, 2216-2219.
97. Vivanco, F., Martin-Ventura, J. L., Duran, M. C., Barderas, M. G. et al., Quest for novel cardiovascular biomarkers by proteomic analysis. J. Proteome Res. 2005, 4, 1181-1191.
98. Miller, H., Poon, S., Hibbert, B., Rayner, K. et al., Modulation of estrogen signaling by the novel interaction of heat shock protein 27, a biomarker for atherosclerosis, and estrogen receptor beta: Mechanistic insight into the vascular effects of estrogens. Arterioscler. Thromb. Vasc. Biol. 2005, 25, e10-e14.
99. Cho, W. C., Yip, T. T., Chung, W. S., Leung, A. W. et al., Differential expression of proteins in kidney, eye, aorta, and serum of diabetic and nondiabetic rats. J. Cell. Biochem. 2006, 99, 256-268.
100. Lam, L., Lind, J., Semsarian, C., Application of proteomics in cardiovascular medicine. Int. J. Cardiol. 2006, 108, 12-19.
101. Fu, Q., Van Eyk, J. E., Proteomics and heart disease: Identifying biomarkers of clinical utility. Expert Rev. Proteomics 2006, 3, 237-249.
102. Smith, C. L., C-reactive protein and asymmetric dimethylarginine: Markers or mediators in cardiovascular disorders? Curr. Pharm. Des. 2007, 13, 1619-1629.
103. Arrell, D. K., Elliott, S. T., Kane, L. A., Guo, Y. et al., Proteomic analysis of pharmacological preconditioning: Novel protein targets converge to mitochondrial metabolism pathways. Circ. Res. 2006, 99, 706-714.
104. Haqqani, A. S., Kelly, J., Baumann, E., Haseloff, R. F. et al., Protein markers of ischemic insult in brain endothelial cells identified using 2-D gel electrophoresis and ICAT-based quantitative proteomics. J. Proteome Res. 2007, 6, 226-239.